Dual-Target Compounds against Type 2 <i>Diabetes Mellitus</i>: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors
A current trend in the quest for new therapies for complex, multifactorial diseases, such as diabetes mellitus (DM), is to find dual or even multi-target inhibitors. In DM, the sodium dependent glucose cotransporter 2 (SGLT2) in the kidneys and the glycogen phosphorylase (GP) in the liver are valida...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2021-04-01
|
| Schriftenreihe: | Pharmaceuticals |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1424-8247/14/4/364 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
